These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11089548)
1. Effects of a calcimimetic compound and naturally activating mutations on the human Ca2+ receptor and on Ca2+ receptor/metabotropic glutamate chimeric receptors. Hauache OM; Hu J; Ray K; Xie R; Jacobson KA; Spiegel AM Endocrinology; 2000 Nov; 141(11):4156-63. PubMed ID: 11089548 [TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain. Hu J; Mora S; Colussi G; Proverbio MC; Jones KA; Bolzoni L; De Ferrari ME; Civati G; Spiegel AM J Bone Miner Res; 2002 Aug; 17(8):1461-9. PubMed ID: 12162500 [TBL] [Abstract][Full Text] [Related]
3. A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+. Hu J; McLarnon SJ; Mora S; Jiang J; Thomas C; Jacobson KA; Spiegel AM J Biol Chem; 2005 Feb; 280(6):5113-20. PubMed ID: 15591042 [TBL] [Abstract][Full Text] [Related]
4. Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor. Ray K; Northup J J Biol Chem; 2002 May; 277(21):18908-13. PubMed ID: 11880385 [TBL] [Abstract][Full Text] [Related]
5. Functional interactions between the extracellular domain and the seven-transmembrane domain in Ca2+ receptor activation. Hauache OM; Hu J; Ray K; Spiegel AM Endocrine; 2000 Aug; 13(1):63-70. PubMed ID: 11051048 [TBL] [Abstract][Full Text] [Related]
6. The Venus Fly Trap domain of the extracellular Ca2+ -sensing receptor is required for L-amino acid sensing. Mun HC; Franks AH; Culverston EL; Krapcho K; Nemeth EF; Conigrave AD J Biol Chem; 2004 Dec; 279(50):51739-44. PubMed ID: 15579475 [TBL] [Abstract][Full Text] [Related]
8. Residue 826 in the calcium-sensing receptor is implicated in the response to calcium and to R-568 calcimimetic compound. Alvarez-Hernández D; González-Suárez I; Fernández-Martín JL; Rodríguez I; Santamaría I; Coto E; Cannata-Andía JB Calcif Tissue Int; 2010 Mar; 86(3):227-33. PubMed ID: 20130845 [TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor. Hu J; Mora S; Weber G; Zamproni I; Proverbio MC; Spiegel AM J Bone Miner Res; 2004 Apr; 19(4):578-86. PubMed ID: 15005845 [TBL] [Abstract][Full Text] [Related]
10. Human Ca2+ receptor cysteine-rich domain. Analysis of function of mutant and chimeric receptors. Hu J; Hauache O; Spiegel AM J Biol Chem; 2000 May; 275(21):16382-9. PubMed ID: 10747888 [TBL] [Abstract][Full Text] [Related]
11. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Nemeth EF; Steffey ME; Hammerland LG; Hung BC; Van Wagenen BC; DelMar EG; Balandrin MF Proc Natl Acad Sci U S A; 1998 Mar; 95(7):4040-5. PubMed ID: 9520489 [TBL] [Abstract][Full Text] [Related]
12. Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by region-specific antipeptide antisera. Chang W; Pratt S; Chen TH; Nemeth E; Huang Z; Shoback D J Bone Miner Res; 1998 Apr; 13(4):570-80. PubMed ID: 9556057 [TBL] [Abstract][Full Text] [Related]
13. Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Hammerland LG; Garrett JE; Hung BC; Levinthal C; Nemeth EF Mol Pharmacol; 1998 Jun; 53(6):1083-8. PubMed ID: 9614212 [TBL] [Abstract][Full Text] [Related]
14. Calcium-sensing receptor and calcimimetic agents. Coburn JW; Elangovan L; Goodman WG; Frazaõ JM Kidney Int Suppl; 1999 Dec; 73():S52-8. PubMed ID: 10633465 [TBL] [Abstract][Full Text] [Related]
15. Prevention of uremic bone disease using calcimimetic compounds. Olgaard K; Lewin E Annu Rev Med; 2001; 52():203-20. PubMed ID: 11160775 [TBL] [Abstract][Full Text] [Related]
16. Calcium sensing receptor activation by a calcimimetic suggests a link between cooperativity and intracellular calcium oscillations. Miedlich S; Gama L; Breitwieser GE J Biol Chem; 2002 Dec; 277(51):49691-9. PubMed ID: 12399473 [TBL] [Abstract][Full Text] [Related]
17. Effects of divalent cations and of a calcimimetic on adrenocorticotropic hormone release in pituitary tumor cells. Ferry S; Chatel B; Dodd RH; Lair C; Gully D; Maffrand JP; Ruat M Biochem Biophys Res Commun; 1997 Sep; 238(3):866-73. PubMed ID: 9325183 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of cell proliferation by calcium and a calcimimetic compound. Mailland M; Waelchli R; Ruat M; Boddeke HG; Seuwen K Endocrinology; 1997 Sep; 138(9):3601-5. PubMed ID: 9275041 [TBL] [Abstract][Full Text] [Related]
19. Calindol, a positive allosteric modulator of the human Ca(2+) receptor, activates an extracellular ligand-binding domain-deleted rhodopsin-like seven-transmembrane structure in the absence of Ca(2+). Ray K; Tisdale J; Dodd RH; Dauban P; Ruat M; Northup JK J Biol Chem; 2005 Nov; 280(44):37013-20. PubMed ID: 16135510 [TBL] [Abstract][Full Text] [Related]
20. The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. Bräuner-Osborne H; Jensen AA; Sheppard PO; O'Hara P; Krogsgaard-Larsen P J Biol Chem; 1999 Jun; 274(26):18382-6. PubMed ID: 10373443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]